| Literature DB >> 30867672 |
Jared E Knickelbein1, Meredith Kim1, Elvira Argon1, Robert B Nussenblatt1, Nida H Sen1.
Abstract
INTRODUCTION: Non-infectious uveitis encompasses a group of inflammatory eye diseases that can cause irreversible vision loss if left untreated or undertreated. In cases requiring stemic treatment, a step-wise treatment approach is often employed starting with corticosteroids for severe active disease, followed by initiation of steroid-sparing therapies to maintain inflammatory control and avoid the abundant complications of long-term corticosteroid use. AREAS COVERED: We review the current high-quality evidence comparing the efficacy of various systemic steroid-sparing agents in the treatment of non-infectious uveitis. For studies to be included, they had to have a prospective, randomized, comparative design or a retrospective design including at least 100 patients. EXPERT COMMENTARY: Given the rarity of uveitis and the heterogeneity of uveitic diseases, there are few randomized controlled studies that directly compare the relative efficacy of the various steroid-sparing immunosuppressive agents. Therefore, current treatment strategies are based mainly on data from observational series.Entities:
Keywords: Non-infectious uveitis; adalimumab; azathioprine; cyclosporine; immunosuppression; infliximab; methotrexate; mofetil; mycophenolate
Year: 2017 PMID: 30867672 PMCID: PMC6411306 DOI: 10.1080/17469899.2017.1319762
Source DB: PubMed Journal: Expert Rev Ophthalmol ISSN: 1746-9899